InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: entdoc post# 96807

Sunday, 09/30/2012 8:13:05 PM

Sunday, September 30, 2012 8:13:05 PM

Post# of 345997
In the same line of reasoning....We know double-armed MAB missile BAVI has great specificity for hypoxia [environ of low oxygen supply-stressed cells, especially the non-mutating cancer blood vessel lining cells, the endothelial cells. Once coupled to the cancer blood vessel endothelial cells Bavi stimulates ingrowth if immune cells specialized at slowly destroying [embolizing] cancer blood vessels. Bavi has a "PPHM exclusive cancer docking site" with mindboggling potential. By binding to the "flipped" cell membrane phospholipid, MAB Bavi has also been dicovered to unmask the cancer as a foreign subastance...not body. We have wondered for decade how cancers evade the immune system. Thorpe and anti-PS investigators have discovered the cause: -PS. When that cell membrane building block flips outside edge in, that signals the body that normal cellular death is proceding. Not to worry. Flipped PS is sine quo non (defines) a normal cellular arc of senescence and death. Other immune cells are called to the area to clean up the mess made by chemo-, irradiation, and surgery, AND sample the cancer to which the cells begin to manufacture "immortal" self-cells that have developed a memory to the fact that the mass is malignant...not self, and then launch a longstanding attack on the cancer. So Bavi is an immunomodulator (it [favorably] affects the immune system, upregulating it. Repeat, Bavi only makes traditional therapy more efective at this stage. Wait until Bavi, a double-armed MAB, can carry cancer poison with it to the tumor. The doubgle-fisted MAB rocket conjugated to a cytotoxin was how this Bavi strategy has evolved against cancer. Along the road to discovery it was discovered that "naked" Bavi packs a statistically signicant wallop all by itself. .
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News